相关实验视频
Updated: Sep 13, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
德国帕金森病住院多学科治疗的用户群:双中心前性观察性研究
Vera Tschentscher1, Judith Oppermann1, Julius Welzel2
1Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, 44791, Bochum, Germany.
老年复合疗法 (GCT) 患者比帕金森病多式复合疗法 (PD-MCT) 患者更老,更受损. 较低的跌倒恐惧和更好的步行速度预测了帕金森病护理中的治疗反应.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 康复医学 康复医学 康复医学
背景情况:
- 德国对帕金森病 (PwP) 的多学科护理主要是基于住院的.
- 在PD多模式综合疗法 (PD-MCT) 和老年综合疗法 (GCT) 之间的患者群体差异尚未得到充分理解.
研究的目的:
- 在现实环境中调查和比较PD-MCT和GCT的用户群.
- 在接受住院多学科康复治疗的患者中确定治疗反应的预测因素.
主要方法:
- 一个双中心的前性观察研究,对PwP进行14天的住院PD-MCT或GCT.
- 在治疗前后收集人口统计,临床和基于设备的步态变量.
- 包括ANCOVA和后勤回归在内的统计分析,以比较群体并确定响应的预测因素.
主要成果:
- 与PD-MCT患者相比,GCT患者的年龄明显较大 (74.7岁与65.6岁),疾病持续时间较长,霍恩和雅尔 (HY) 阶段较高.
- GCT使用者在下肢功能 (SPPB),认知功能 (MoCA,TMT),生活质量和更高的跌倒恐惧 (FES-I) 中表现较差.
- 经过年龄调整后,步行参数的显著差异仍然存在,GCT用户的步行速度和步骤长度减少. 较低的跌倒恐惧和更快的步行速度预测了治疗反应.
结论:
- 与PD-MCT患者相比,老年复合疗法患者的年龄和疾病严重程度更高,特别是运动障碍.
- 目前的患者群体可能与PD-MCT和GCT的国家预期目标不一致.
- 建议对医疗保险数据进行进一步分析,以优化多学科帕金森病护理策略.
更多相关视频
09:19Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
相关概念视频
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Specialized Care Centers and Settings-II
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Drug Therapy
Antianxiety Medications